Target Name: HYCC2
NCBI ID: G285172
Review Report on HYCC2 Target / Biomarker Content of Review Report on HYCC2 Target / Biomarker
HYCC2
Other Name(s): FLJ37917 | FLJ10981 | HYCC2 variant 1 | Protein FAM126B (isoform 1) | F126B_HUMAN | FLJ42947 | Protein FAM126B | hyccin PI4KA lipid kinase complex subunit 2 | Hyccin PI4KA lipid kinase complex subunit 2, transcript variant 1 | family with sequence similarity 126 member B | FAM126B | OTTHUMP00000163723 | MGC39518

Heat Shock Protein 2: HYCC2's Role in Cellular Processes

HYCC2 (FLJ37917) is a protein that is expressed in various tissues of the body, including the brain, heart, liver, and pancreas. Its full name is heat shock protein 2, and it is a member of the HSP70 family. HSP70s are a group of proteins that are known to play a crucial role in the regulation of protein folding and stability, and they are involved in a wide range of cellular processes, including stress responses, DNA replication, and protein-protein interactions.

One of the defining features of HYCC2 is its ability to induce a heat shock response in cells. This is an important function of HSP70s, as it allows them to survive and function in conditions that would otherwise be deadly, such as high temperatures or the presence of toxins. When cells are exposed to heat, HSP70s can induce a series of changes that help the cells adapt to the stressor, such as increasing the production of certain proteins that help to protect the cell from damage.

HYCC2 is also known for its role in the regulation of protein stability. In addition to its ability to induce a heat shock response, HSP70s can also help to regulate the stability of other proteins. This is important because the stability of proteins is closely linked to their function, and changes in protein stability can have a significant impact on the activity and stability of a cell.

One of the key challenges in studying HYCC2 is its complex structure. HSP70s are known for their ability to exist in a variety of conformations, and it is not always clear how these different conformations relate to their function. Researchers have used a variety of techniques, such as biochemical assays and structural studies, to try to understand the structure and function of HYCC2.

One of the key findings in these studies is that HYCC2 is involved in a wide range of cellular processes, including the regulation of protein function, cell signaling, and stress responses. For example, studies have shown that HYCC2 is involved in the regulation of the activity of several enzymes, including the protein kinase kinase A1 (PKA) and the transcription factor binding protein 5 (TFBP5).

In addition to its role in cellular signaling, HYCC2 is also of interest as a potential drug target. Studies have shown that HSP70s can be targeted with small molecules, and that these targets can be used to modulate a wide range of cellular processes, including protein function and stability. This suggests that HYCC2 and other HSP70s may be useful targets for the development of new therapeutic compounds.

In conclusion, HYCC2 is a protein that is involved in a wide range of cellular processes, including the regulation of protein function, cell signaling, and stress responses. Its ability to induce a heat shock response and regulate protein stability make it an interesting candidate as a potential drug target. Further research is needed to fully understand the function and potential applications of HYCC2, but its study is significant as it gives us new insights on the complex role of HSP70s in the cell.

Protein Name: Hyccin PI4KA Lipid Kinase Complex Subunit 2

Functions: Component of a complex required to localize phosphatidylinositol 4-kinase (PI4K) to the plasma membrane

The "HYCC2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HYCC2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

HYDIN | HYI | HYKK | HYLS1 | HYMAI | HYOU1 | HYPK | Hypoxia inducible factor (HIF) | Hypoxia-Inducible Factor Prolyl Hydroxylase | I-kappa-B-kinase (IKK) complex | IAH1 | IAPP | IARS1 | IARS2 | IATPR | IBA57 | IBA57-DT | IBSP | IBTK | ICA1 | ICA1L | ICAM1 | ICAM2 | ICAM3 | ICAM4 | ICAM5 | ICE1 | ICE2 | ICMT | ICMT-DT | ICOS | ICOSLG | ID1 | ID2 | ID2-AS1 | ID2B | ID3 | ID4 | IDE | IDH1 | IDH1-AS1 | IDH2 | IDH2-DT | IDH3A | IDH3B | IDH3G | IDI1 | IDI2 | IDI2-AS1 | IDNK | IDO1 | IDO2 | IDS | IDSP1 | IDUA | IER2 | IER3 | IER3-AS1 | IER3IP1 | IER5 | IER5L | IER5L-AS1 | IFFO1 | IFFO2 | IFI16 | IFI27 | IFI27L1 | IFI27L2 | IFI30 | IFI35 | IFI44 | IFI44L | IFI6 | IFIH1 | IFIT1 | IFIT1B | IFIT2 | IFIT3 | IFIT5 | IFITM1 | IFITM10 | IFITM2 | IFITM3 | IFITM3P2 | IFITM3P7 | IFITM4P | IFITM5 | IFITM8P | IFITM9P | IFNA1 | IFNA10 | IFNA12P | IFNA13 | IFNA14 | IFNA16 | IFNA17 | IFNA2 | IFNA21 | IFNA22P | IFNA4